 |
|
US prostate cancer deaths down one third in men aged 50-74: Europe following?
September 21, 2003Copenhagen, Denmark: New findings presented today (Tuesday 23 September) at ECCO 12 - The European Cancer Conference, show that US prostate cancer mortality rates, which had been increasing slowly during the 1970s and 1980s, suddenly started to fall rapidly during the 1990s.
Between 1990 and 2000, US prostate cancer mortality fell by one third at ages 50-74, and it fell by one quarter at ages 75-84. Definite decreases are also beginning to be seen in the UK, France and some other European countries.
Early detection, prompt surgery and hormonal treatments are all contributing, according to Professor Sir Richard Peto, from the University of Oxford, UK.
He said: "Both in the US and in the UK, the mortality rates from prostate cancer are now falling fast: two of the main reasons are earlier diagnosis and wide use of hormonal treatments."
Otilia Dalesio, Director of Biometrics at the Netherlands Cancer Institute and co-ordinator of the Prostate Cancer Trialists' Collaborative Group, commented: "For prostate cancer, as for breast cancer, early diagnosis and immediate hormonal treatment can improve 10-year survival."
Even after successful surgery, a few cancer cells may remain undetected nearby (where they can often be controlled by radiotherapy) or in distant parts of the body (where they cannot, and may eventually get out of control and cause death). One way of controlling distant fragments of prostate cancer - or of breast cancer - is by hormonal therapy, which prevents the fragments from being stimulated into becoming more malignant and dangerous by the body's own sex hormones.
Randomised trials have shown that, following successful surgery, a few years of hormonal treatment substantially reduces the 10-year risk of death from prostate or breast cancer.
The most widely used anti-hormonal treatment for breast cancer has been tamoxifen, although other drugs are now available. UK and US breast cancer death rates in middle age have fallen by about one-third since 1990.
The most widely used hormonal treatment for prostate cancer has been surgical castration (removing the testes, which produce the male sex hormone testosterone), but anti-hormonal drugs for prostate cancer are now available that can be used instead of castration.
(ends)
Abstract no: 328 (Tuesday 23 September, 10.45 hrs CET, The best of oncology in 2003 plenary session)
MW Communications
He said: "Both in the US and in the UK, the mortality rates from prostate cancer are now falling fast: two of the main reasons are earlier diagnosis and wide use of hormonal treatments."
Otilia Dalesio, Director of Biometrics at the Netherlands Cancer Institute and co-ordinator of the Prostate Cancer Trialists' Collaborative Group, commented: "For prostate cancer, as for breast cancer, early diagnosis and immediate hormonal treatment can improve 10-year survival."
Even after successful surgery, a few cancer cells may remain undetected nearby (where they can often be controlled by radiotherapy) or in distant parts of the body (where they cannot, and may eventually get out of control and cause death). One way of controlling distant fragments of prostate cancer - or of breast cancer - is by hormonal therapy, which prevents the fragments from being stimulated into becoming more malignant and dangerous by the body's own sex hormones.
Randomised trials have shown that, following successful surgery, a few years of hormonal treatment substantially reduces the 10-year risk of death from prostate or breast cancer.
The most widely used anti-hormonal treatment for breast cancer has been tamoxifen, although other drugs are now available. UK and US breast cancer death rates in middle age have fallen by about one-third since 1990.
The most widely used hormonal treatment for prostate cancer has been surgical castration (removing the testes, which produce the male sex hormone testosterone), but anti-hormonal drugs for prostate cancer are now available that can be used instead of castration.
(ends)
Abstract no: 328 (Tuesday 23 September, 10.45 hrs CET, The best of oncology in 2003 plenary session)
MW Communications
Breast Cancer Current Events and Breast Cancer News RSSUCLA researchers create 'fly paper' to capture circulating cancer cells
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.
Fertility procedures need not delay breast cancer treatment for younger women
A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.
Coffee break: Compound brewing new research in colon, breast cancer
A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists.
Drugs to treat anemia in cancer patients linked to thromboembolism
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Discovery in worms by Queen's researchers points to more targeted cancer treatment
Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment.
FDA approved leukemia drugs shows promise in ovarian cancer cells
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.
Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe
The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated.
Scientists uncover new key to the puzzle of hormone therapy and breast cancer
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer.
Breast density associated with increased risk of cancer recurrence
A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation.
Researcher: 'Optical biopsy' for breast cancer increasingly accurate
But women may not have to endure the medical costs, stress and potential complications that accompany such invasive biopsies forever. A University of Florida biomedical engineering researcher is making progress on an "optical biopsy" that has the potential to determine whether growths are cancerous without ever puncturing the skin.
More Breast Cancer Current Events and Breast Cancer News Articles
 |
New Balance Women's Lace Up X Out Breast Cancer Tech Tee (Athletic Grey, Small) by New Balance The New Balance X Out Breast Caner Tee has a soft hand and clearly states how everyone feels! |
 |
1149 WOMENS VINTAGE BLACK ADJUSTABLE FATIGUE CAP w/PINK STRIPES & ''BREAST CANCER'' RIBBON by Rothco A portion of these proceeds go to the Babylon Breast Cancer Coalition- For Life, For Hope, For Change, For the Future Visit www.babylonbreastcancer.org for more information. |
 |
Breast Cancer Survival Manual, Fourth Edition: A Step-by-Step Guide for the Woman With Newly Diagnosed Breast Cancer by John Link (Author) A completely updated edition of the definitive guide for patients with breast cancer The new fourth edition of The Breast Cancer Survival Manual provides essential updates on treatment and care, enhancing the basic information that has made this the most trusted guide for women diagnosed with breast cancer for the past decade. This edition includes the most current advice on • getting a second opinion: why it’s important, what questions to ask, and how to decide which team of doctors is best for you • updates on genetic testing and how doctors are using the results to tailor care for each patient • navigating new types of radiation, the herceptin breakthrough, and improved reconstruction surgeries Conscious of the rapidly evolving spectrum of... |
 |
Sunbeam SlumberRest Camelot Microplush Heated Throw, Breast Cancer Awareness Pink by Sunbeam Soft comfortable fabric that you can cuddle up with anywhere in your house. Use it on the couch while curling up to read a good book or in a chair while watching your favorite show. This throw is 50"x60", with a primstyle control which features 3 warming settings and 3 hour auto-off. So turn on your warming blanket, turn off your thermostat and save on your heating bill. Warm up to a good cause! Sunbeam is joining the fight against breast cancer. Through the purchase of this pink throw, sunbeam will donate $1.00 to city of hope for breast cancer research, treatment and education* up to $25,000. Program ends april 30, 2009. "to save lives and end breast cancer forever by empowering people, ensuring quality care for all, and energizing science to find the cures." *to learn more about... |
 |
Hope Courage Strength Pink Ribbon Breast Cancer Awareness Expressively Yours Bracelet by MyJewelThief |
 |
Wrangler Women's Tough Enough To Wear Pink Breast Cancer Awareness Jacket,Pink,X-Large by Wrangler Are you tough enough to wear pink? That is the question the western industry asked 12/9/05 at the Wrangler National Finals Rodeo (Wrangler NFR), the "Super Bowl of pro rodeo," as it launched Tough Enough to Wear Pink (TETWP). TETWP is a multi-year, western-industry-wide fundraiser to raise awareness and funds for breast cancer research. TETWP partners are ponying up to support this cause by manufacturing pink merchandise with proceeds benefiting breast cancer research. By wearing this Tough Enough to Wear Pink shirt you are helping in the fight against breast cancer. This TETWP shirt is a pink cotton plaid. Import. Tough Enough to Wear Pink. long sleeve zip front jacket with zippered front slash pockets and the breast cancer embroidery on left chest. 100% Polyester Fleece/100% Nylon... |
 |
Find the Cure Pink Breast Cancer Awareness Wristband by sci Find The Cure Pink Breast Cancer Awareness wristband |
 |
Just Get Me Through This!: The Practical Guide to Breast Cancer by Deborah A. Cohen (Author), M.D., Robert M. Gelfand (Author) |
 |
Raymond Geddes National Breast Cancer Foundation Pen (67709) by Raymond Geddes Breast Cancer Awareness Pen, Join Geddes in supporting the National Breast Cancer Foundation and the fight against Breast Cancer. Assortment contains pink pens with pink ribbons. Retractable, black in pen ink. 5 1/2" long. |
 |
Thermos Intak Breast Cancer Awareness 26-Ounce Hydration Bottle by Thermos Nissan Thermos Intak breast cancer awareness hydration bottle is made from bpa free, impact- resistant, dishwasher durable eastman tritan copolyester. The leak-proof lid has an integrated carrying loop. Ideal for water, iced tea, juices and sports drinks: tritan material will not retain flavors or odors of liquid contents. Thermos will donate 3-percent of pink ribbon sales to support breast cancer initiatives. |
| © 2009 BrightSurf.com |